Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology - PubMed (original) (raw)
Review
Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology
Genís Oña et al. Curr Med Chem. 2021.
Abstract
In the drug development, the formation of highly selective ligands has been unsuccessful in the treatment of central nervous system disorders. Multi-target ligands, from the polypharmacology paradigm, are being proposed as treatments for these complex disorders, since they offer enhanced efficacy and a strong safety profile. Natural products are the best examples of multi-target compounds, so they are of high interest within this paradigm. Additionally, recent research on psychoactive drugs of natural origin, such as ayahuasca and cannabis, has demonstrated the promising therapeutic potential for the treatment of some psychiatric and neurological disorders. In this text, we describe how research on psychoactive drugs can be effectively combined with the polypharmacology paradigm, providing ayahuasca and cannabis research as examples. The advantages and disadvantages are also discussed.
Keywords: Polypharmacology; ayahuasca; cannabis; multi-target; plant; psychoactive; therapeutic.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
- Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
Zhang W, Bai Y, Wang Y, Xiao W. Zhang W, et al. Curr Pharm Des. 2016;22(21):3171-81. doi: 10.2174/1381612822666160224142812. Curr Pharm Des. 2016. PMID: 26907941 Review. - Polypharmacology or "Pharmacological Promiscuity" In Psychedelic Research: What Are We Missing?
Ona GS, Dos Santos RG, Hallak JEC, Bouso JC. Ona GS, et al. ACS Chem Neurosci. 2020 Oct 21;11(20):3191-3193. doi: 10.1021/acschemneuro.0c00614. Epub 2020 Oct 6. ACS Chem Neurosci. 2020. PMID: 33021777 - Biomedical analysis of New Psychoactive Substances (NPS) of natural origin.
Lo Faro AF, Di Trana A, La Maida N, Tagliabracci A, Giorgetti R, Busardò FP. Lo Faro AF, et al. J Pharm Biomed Anal. 2020 Feb 5;179:112945. doi: 10.1016/j.jpba.2019.112945. Epub 2019 Oct 30. J Pharm Biomed Anal. 2020. PMID: 31704129 Review. - The polypharmacology of natural products.
Ho TT, Tran QT, Chai CL. Ho TT, et al. Future Med Chem. 2018 Jun 1;10(11):1361-1368. doi: 10.4155/fmc-2017-0294. Epub 2018 Apr 20. Future Med Chem. 2018. PMID: 29673257 Review. - Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
Ravikumar B, Aittokallio T. Ravikumar B, et al. Expert Opin Drug Discov. 2018 Feb;13(2):179-192. doi: 10.1080/17460441.2018.1413089. Epub 2017 Dec 12. Expert Opin Drug Discov. 2018. PMID: 29233023 Review.
Cited by
- Depression: An Insight into Heterocyclic and Cyclic Hydrocarbon Compounds Inspired from Natural Sources.
Shah AJ, Mir RH, Mohi-Ud-Din R, Pottoo FH, Masoodi MH, Bhat ZA. Shah AJ, et al. Curr Neuropharmacol. 2021;19(11):2020-2037. doi: 10.2174/1570159X19666210426115234. Curr Neuropharmacol. 2021. PMID: 33902421 Free PMC article. - Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.
Olson DE. Olson DE. Biochemistry. 2022 Feb 1;61(3):127-136. doi: 10.1021/acs.biochem.1c00812. Epub 2022 Jan 21. Biochemistry. 2022. PMID: 35060714 Free PMC article. Review. - The Use of Cannabis sativa L. for Pest Control: From the Ethnobotanical Knowledge to a Systematic Review of Experimental Studies.
Ona G, Balant M, Bouso JC, Gras A, Vallès J, Vitales D, Garnatje T. Ona G, et al. Cannabis Cannabinoid Res. 2022 Aug;7(4):365-387. doi: 10.1089/can.2021.0095. Epub 2021 Oct 5. Cannabis Cannabinoid Res. 2022. PMID: 34612729 Free PMC article. Review. - Herbal medicine for post-stroke insomnia: A protocol for systematic review and meta-analysis.
Kim SH, Lim JH. Kim SH, et al. Medicine (Baltimore). 2021 Jun 4;100(22):e26223. doi: 10.1097/MD.0000000000026223. Medicine (Baltimore). 2021. PMID: 34087901 Free PMC article. - Psychedelic-inspired approaches for treating neurodegenerative disorders.
Saeger HN, Olson DE. Saeger HN, et al. J Neurochem. 2022 Jul;162(1):109-127. doi: 10.1111/jnc.15544. Epub 2021 Dec 5. J Neurochem. 2022. PMID: 34816433 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources